We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FAF icon
251
First American
FAF
$7.37B
$1.65M 0.13%
+25,132
New +$1.59M
CVS icon
252
CVS Health
CVS
$120B
$1.64M 0.13%
+24,270
New +$1.45M
TIGO icon
253
Millicom
TIGO
$16.3B
$1.64M 0.13%
54,314
+21,781
+67% +$600K
FSM icon
254
Fortuna Silver Mines
FSM
$3.25B
$1.64M 0.13%
269,473
+93,563
+53% +$465K
SBAC icon
255
SBA Communications
SBAC
$19.4B
$1.63M 0.13%
7,412
-1,235
-14% -$259K
OUT icon
256
Outfront Media
OUT
$5.31B
$1.62M 0.12%
+100,288
New +$1.79M
MOH icon
257
Molina Healthcare
MOH
$10.5B
$1.61M 0.12%
+4,897
New +$1.48M
SBRA icon
258
Sabra Healthcare REIT
SBRA
$5.16B
$1.61M 0.12%
91,936
+68,246
+288% +$1.15M
ED icon
259
Consolidated Edison
ED
$39.8B
$1.59M 0.12%
14,339
-40,743
-74% -$4M
RPRX icon
260
Royalty Pharma
RPRX
$26.2B
$1.58M 0.12%
50,900
-44,320
-47% -$1.4M
BIIB icon
261
Biogen
BIIB
$30.3B
$1.58M 0.12%
11,573
-18,936
-62% -$2.71M
ONC
262
BeOne Medicines Ltd
ONC
$40.6B
$1.57M 0.12%
+5,774
New +$1.35M
SRCE icon
263
1st Source
SRCE
$2.13B
$1.57M 0.12%
26,271
+485
+2% +$29.9K
FNB icon
264
FNB Corp
FNB
$6.81B
$1.57M 0.12%
116,699
-154,552
-57% -$2.27M
BIO icon
265
Bio-Rad Laboratories Class A
BIO
$9.46B
$1.57M 0.12%
+6,443
New +$1.94M
SXI icon
266
Standex International
SXI
$4.02B
$1.56M 0.12%
+9,680
New +$1.77M
IMMR icon
267
Immersion
IMMR
$245M
$1.56M 0.12%
205,186
+62,721
+44% +$515K
HLF icon
268
Herbalife
HLF
$1.23B
$1.55M 0.12%
179,871
+150,715
+517% +$1.07M
VICI icon
269
VICI Properties
VICI
$28.7B
$1.55M 0.12%
47,470
-26,096
-35% -$804K
RGA icon
270
Reinsurance Group of America
RGA
$16B
$1.55M 0.12%
+7,849
New +$1.63M
EGBN icon
271
Eagle Bancorp
EGBN
$870M
$1.54M 0.12%
+73,412
New +$1.74M
BLBD icon
272
Blue Bird Corp
BLBD
$2.04B
$1.53M 0.12%
47,202
+7,260
+18% +$266K
HSTM icon
273
HealthStream
HSTM
$825M
$1.51M 0.12%
47,062
-969
-2% -$31.4K
SEIC icon
274
SEI Investments
SEIC
$12.5B
$1.51M 0.12%
19,421
+7,285
+60% +$586K
GNTX icon
275
Gentex
GNTX
$4.94B
$1.5M 0.12%
64,342
-10,760
-14% -$275K
9 10
11
12 13

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.